Use of pharmacoeconomic data in making hospital formulary decisions

Folakemi T. Odedina, Johanna Sullivan, Rowena Nash, C. Denise Clemmons

Research output: Contribution to journalArticlepeer-review

Abstract

The use of pharmacoeconomic data in hospital formulary decisions was explored. Data were collected from pharmacist members of pharmacy and therapeutics (P&T) committees in 204 Florida hospitals. Participants were asked, via a cross-sectional telephone survey, to rate 10 factors used in making formulary decisions from 1 (most important) to 10 (least important). Participants were also asked about the usual sources of pharmacoeconomic data used by the P&T committee, the types of pharmacoeconomic analyses and humanistic outcome measures that have been used by the P&T committee to make formulary decisions, and the availability of someone with pharmacoeconomic skills to assist with the formulary decision-making. The average time spent collecting data was 19 minutes. Data were analyzed using descriptive statistics and correlation analysis. Eighty-six percent of the participants indicated that pharmacoeconomic data were used all the time or very often when formulary decisions were made, with only 6% stating that these data were rarely or never used. Pharmacoeconomic data were rated by 63% of participants to be very important in formulary decisions. The usual sources of pharmacoeconomic data listed by participants are inhouse data (75%), published literature (57%), and pharmaceutical industry studies (13%). Participants rated drug efficacy, toxicity, and side effects as the most important and avoiding use of home infusions as the least important factors in making hospital formulary decisions. About 70% of the hospitals had someone with pharmacoeconomic skills on staff, while 4% reported consulting with an external pharmacoeconomics expert. Most P&T committees in Florida hospitals relied on pharmacoeconomic data to assist them in making formulary decisions.

Original languageEnglish (US)
Pages (from-to)1441-1444
Number of pages4
JournalAmerican Journal of Health-System Pharmacy
Volume59
Issue number15
DOIs
StatePublished - Aug 1 2002

Keywords

  • Administration
  • Data collection
  • Formularies
  • Pharmacoeconomics
  • Pharmacy and therapeutics committee
  • Pharmacy, institutional, hospital

ASJC Scopus subject areas

  • Pharmacology
  • Health Policy

Fingerprint

Dive into the research topics of 'Use of pharmacoeconomic data in making hospital formulary decisions'. Together they form a unique fingerprint.

Cite this